123 related articles for article (PubMed ID: 6364892)
1. Lack of effect of cyclandelate in peripheral arterial disease.
Vyden JK; Nagasawa K; Kanazawa M; Rose HB; Seino Y; Groseth-Robertson MF; Lander EB; Elconin SB
Angiology; 1984 Jan; 35(1):1-11. PubMed ID: 6364892
[TBL] [Abstract][Full Text] [Related]
2. Cyclandelate: effect on circulatory measurements and exercise tolerance in chronic arterial insufficiency of the lower limbs.
Reich T
J Am Geriatr Soc; 1977 May; 25(5):202-5. PubMed ID: 853204
[TBL] [Abstract][Full Text] [Related]
3. Effect of cyclandelate on dementia.
Westreich G; Alter M; Lundgren S
Stroke; 1975; 6(5):535-8. PubMed ID: 1101457
[TBL] [Abstract][Full Text] [Related]
4. Cyclandelate in the treatment of cerebral arteriosclerosis.
Hall P
J Am Geriatr Soc; 1976 Jan; 24(1):41-5. PubMed ID: 811704
[TBL] [Abstract][Full Text] [Related]
5. Effects of cyclandelate on diabetic peripheral neuropathy.
Canal N; Comi G; Marchettini P; Pozza G
Br J Clin Pract Suppl; 1984; 34():62-8. PubMed ID: 6430326
[No Abstract] [Full Text] [Related]
6. The effect of cyclandelate in depressed and demented patients: a controlled study in psychogeriatric patients.
Davies G; Hamilton S; Hendrickson E; Levy R; Post F
Age Ageing; 1977 Aug; 6(3):156-62. PubMed ID: 331919
[TBL] [Abstract][Full Text] [Related]
7. Cyclandelate in long standing cerebral arteriosclerosis.
Rogers WF; Shaikh VA; Clark AN
Gerontol Clin (Basel); 1970; 12(2):88-93. PubMed ID: 4987660
[No Abstract] [Full Text] [Related]
8. Cyclandelate in the treatment of senile mental changes: a double-blind evaluation.
Rao DB; Georgiev EL; Paul PD; Guzman AB
J Am Geriatr Soc; 1977 Dec; 25(12):548-51. PubMed ID: 336670
[TBL] [Abstract][Full Text] [Related]
9. Comparative efficacy of cyclandelate versus flunarizine in the prophylactic treatment of migraine.
Nappi G; Sandrini G; Savoini G; Cavallini A; de Rysky C; Micieli G
Drugs; 1987; 33 Suppl 2():103-9. PubMed ID: 3304950
[TBL] [Abstract][Full Text] [Related]
10. The effect of cyclandelate on cholesterol metabolism in patients with familial hypercholesterolaemia.
Gevers Leuven JA; vd Voort H; Kempen HJ; de Wit E; Havekes L
Drugs; 1987; 33 Suppl 2():131-5. PubMed ID: 3304952
[TBL] [Abstract][Full Text] [Related]
11. Treatment of early diabetic retinopathy with cyclandelate.
Cunha-Vaz JG; Reis Fonseca J; Hagenouw JR
Br J Ophthalmol; 1977 Jun; 61(6):399-404. PubMed ID: 326306
[TBL] [Abstract][Full Text] [Related]
12. Beta blockade and intermittent claudication.
Lepäntalo M
Acta Med Scand Suppl; 1985; 700():1-48. PubMed ID: 2865873
[TBL] [Abstract][Full Text] [Related]
13. Cyclandelate in the treatment of senility: a controlled study.
Capote B; Parikh N
J Am Geriatr Soc; 1978 Aug; 26(8):360-2. PubMed ID: 353121
[TBL] [Abstract][Full Text] [Related]
14. Multifocal infarct dementia treated by cyclandelate and monitored by quantitative EEG.
Harding GF; Hall P; Young J; Smith GA
Angiology; 1978 Feb; 29(2):139-40. PubMed ID: 347986
[No Abstract] [Full Text] [Related]
15. Effect of L-carnitine on the reactive hyperemia in patients affected by peripheral vascular disease: a double-blind, crossover study.
Brevetti G; Attisano T; Perna S; Rossini A; Policicchio A; Corsi M
Angiology; 1989 Oct; 40(10):857-62. PubMed ID: 2679240
[TBL] [Abstract][Full Text] [Related]
16. Cyclandelate versus flunarizine. A double-blind study in a selected group of patients with dementia.
Albizzati MG; Bassi S; Calloni E; Sbacchi M; Piolti R; Frattola L
Drugs; 1987; 33 Suppl 2():90-6. PubMed ID: 3304956
[TBL] [Abstract][Full Text] [Related]
17. [Efficacy of an etofylline-cyclandelate combination in age-dependent cerebrovascular insufficiency].
Foltyn P; Lücker PW; Schnitker J
Arzneimittelforschung; 1982; 32(10):1322-8. PubMed ID: 6891235
[TBL] [Abstract][Full Text] [Related]
18. Clinical experience with cyclandelate in insulin-dependent diabetic patients with neuropathy.
De Leeuw IH; Van Rooy P; Moeremans M; Driessens M
Drugs; 1987; 33 Suppl 2():125-30. PubMed ID: 3304951
[TBL] [Abstract][Full Text] [Related]
19. Specific effects of cyclandelate on memory.
Ananth J
Drugs; 1987; 33 Suppl 2():97-102. PubMed ID: 3622311
[TBL] [Abstract][Full Text] [Related]
20. Chronic cerebrovascular disorders: a clinical study with cyclandelate.
Bassi S; Albizzati MG; Sbacchi M; Frattola L
Br J Clin Pract; 1984 Oct; 38(10):344-9. PubMed ID: 6498057
[No Abstract] [Full Text] [Related]
[Next] [New Search]
